Invesaro

Stocks Comparison

CONMED vs Outset Medical: revenue, profit, margins and growth compared

CONMED brought in $1.4B of revenue in fiscal 2025, Outset Medical $119.5M in fiscal 2025. Revenue changed by +5.2% at CONMED and +5.1% at Outset Medical on the year before, so CONMED grew faster. CONMED kept 3.4% of its revenue as net profit, Outset Medical -68.3%. Free cash flow was $150.9M at CONMED and -$47.1M at Outset Medical.

Side by side, latest fiscal year

CNMDOM
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.4B$119.5M
Revenue growth+5.2%+5.1%
Net income$47.1M-$81.7M
Net margin3.4%-68.3%
Free cash flow$150.9M-$47.1M
Free cash flow margin11.0%-39.4%
Earnings per share (diluted)$1.51-$5.37
Cash$40.8M$35M
Debt$834.9M$96.2M
Price to earnings30.1n/a
Market value$1.4B$57.3M
Dividend yield1.32%n/a
Rank by revenue in sector#131 of 523 · Health care#287 of 523 · Health care

Over the years

Revenue
CNMD FY2018: $859.6MCNMD FY2019: $955.1MCNMD FY2020: $862.5MCNMD FY2021: $1BCNMD FY2022: $1BCNMD FY2023: $1.2BCNMD FY2024: $1.3BCNMD FY2025: $1.4BOM FY2018: $2MOM FY2020: $15.1MOM FY2020: $49.9MOM FY2021: $102.6MOM FY2022: $115.4MOM FY2023: $130.4MOM FY2024: $113.7MOM FY2025: $119.5MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $1.4BOM $119.5M
Net income
CNMD FY2018: $40.9MCNMD FY2019: $28.6MCNMD FY2020: $9.5MCNMD FY2021: $62.5MCNMD FY2022: -$80.6MCNMD FY2023: $64.5MCNMD FY2024: $132.4MCNMD FY2025: $47.1MOM FY2018: -$49.8MOM FY2020: -$68.3MOM FY2020: -$121.5MOM FY2021: -$131.9MOM FY2022: -$163MOM FY2023: -$172.8MOM FY2024: -$128MOM FY2025: -$81.7MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $47.1MOM -$81.7M
Net margin
CNMD FY2018: 4.8%CNMD FY2019: 3.0%CNMD FY2020: 1.1%CNMD FY2021: 6.2%CNMD FY2022: -7.7%CNMD FY2023: 5.2%CNMD FY2024: 10.1%CNMD FY2025: 3.4%OM FY2018: -2,480.3%OM FY2020: -453.0%OM FY2020: -243.3%OM FY2021: -128.6%OM FY2022: -141.2%OM FY2023: -132.5%OM FY2024: -112.6%OM FY2025: -68.3%FY18FY19FY20FY21FY22FY23FY24FY25
CNMD 3.4%OM -68.3%
Revenue growth
CNMD FY2019: +11.1%CNMD FY2020: -9.7%CNMD FY2021: +17.2%CNMD FY2022: +3.4%CNMD FY2023: +19.1%CNMD FY2024: +5.0%CNMD FY2025: +5.2%OM FY2020: +651.3%OM FY2020: +231.2%OM FY2021: +105.5%OM FY2022: +12.4%OM FY2023: +13.0%OM FY2024: -12.8%OM FY2025: +5.1%FY19FY20FY21FY22FY23FY24FY25
CNMD +5.2%OM +5.1%
Free cash flow
CNMD FY2018: $58.2MCNMD FY2019: $75.1MCNMD FY2020: $51.5MCNMD FY2021: $96.9MCNMD FY2022: $11.6MCNMD FY2023: $106.3MCNMD FY2024: $153.9MCNMD FY2025: $150.9MOM FY2018: -$48.2MOM FY2020: -$73.6MOM FY2020: -$108.1MOM FY2021: -$133.4MOM FY2022: -$154.1MOM FY2023: -$134.8MOM FY2024: -$117.2MOM FY2025: -$47.1MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $150.9MOM -$47.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about CONMED and Outset Medical

Which is bigger by revenue, CONMED or Outset Medical?

CONMED is bigger by revenue: $1.4B in fiscal 2025, against $119.5M for Outset Medical in fiscal 2025.

Which keeps more of its revenue as profit, CONMED or Outset Medical?

CONMED had a net margin of 3.4% in fiscal 2025; Outset Medical had -68.3% in fiscal 2025.

Which grew revenue faster, CONMED or Outset Medical?

In their latest fiscal years revenue changed by +5.2% at CONMED and +5.1% at Outset Medical.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies